107 related articles for article (PubMed ID: 1745065)
1. Effect of aging and other factors on monocyte aryl hydrocarbon hydroxylase activity.
Putnam AD; Peterson TC
Mech Ageing Dev; 1991 Sep; 60(1):61-74. PubMed ID: 1745065
[TBL] [Abstract][Full Text] [Related]
2. Age, smoking and the activity of the mono-oxygenase aryl hydrocarbon hydroxylase in isolated human peripheral blood monocytes.
George G; O'Mahony S; Woodhouse K
Age Ageing; 1994 Sep; 23(5):421-4. PubMed ID: 7825491
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1, platelet derived growth factor, free radicals and monocyte aryl hydrocarbon hydroxylase activity in liver disease. Role of cell communication.
Peterson TC
Biochem Pharmacol; 1992 Mar; 43(5):1163-6. PubMed ID: 1554389
[TBL] [Abstract][Full Text] [Related]
4. The association of age with the induction of drug-metabolizing enzymes in human monocytes.
George G; Wynne HA; Woodhouse KW
Age Ageing; 1990 Nov; 19(6):364-7. PubMed ID: 2285002
[TBL] [Abstract][Full Text] [Related]
5. Monocyte aryl hydrocarbon hydroxylase (AHH) activity mimics Kupffer cell and hepatocyte AHH activity in an animal model of liver disease.
Peterson TC; Williams CN; Malatjalian DA
Can J Physiol Pharmacol; 1991 Dec; 69(12):1797-803. PubMed ID: 1802352
[TBL] [Abstract][Full Text] [Related]
6. Monocyte arylhydrocarbon hydroxylase activity and mortality.
Peterson TC
Clin Invest Med; 1991 Feb; 14(1):72-6. PubMed ID: 2040107
[TBL] [Abstract][Full Text] [Related]
7. Blood monocyte aryl hydrocarbon hydroxylase activity in psoriasis.
Mason G; Rawlins MD; Shuster S
Br J Clin Pharmacol; 1983 Sep; 16(3):333-5. PubMed ID: 6313027
[TBL] [Abstract][Full Text] [Related]
8. Depression of peripheral blood monocyte aryl hydrocarbon hydroxylase activity in patients with liver disease: possible involvement of macrophage factors.
Peterson TC; Williams CN
Hepatology; 1987; 7(2):333-7. PubMed ID: 3557313
[TBL] [Abstract][Full Text] [Related]
9. Aryl hydrocarbon hydroxylase in human bronchial epithelium and blood monocyte.
Kahng MW; Smith MW; Trump BF
J Natl Cancer Inst; 1981 Feb; 66(2):227-32. PubMed ID: 6935473
[TBL] [Abstract][Full Text] [Related]
10. Drug-metabolizing enzymes in rat, mouse, pig and human macrophages and the effect of phagocytic activation.
Peterson TC
Biochem Pharmacol; 1987 Nov; 36(22):3911-6. PubMed ID: 3689428
[TBL] [Abstract][Full Text] [Related]
11. Alterations in leukocyte aryl hydrocarbon hydroxylase activity associated with treatment and age in psoriasis patients and healthy individuals.
Kraemer KH; Robinson RC; Tarone RE; Protic-Sabljic M; Gelboin HV
Arch Dermatol Res; 1984; 276(2):105-10. PubMed ID: 6721570
[TBL] [Abstract][Full Text] [Related]
12. Aryl hydrocarbon hydroxylase activity in cultured lymphocytes of psoriatic patients.
Kärki NT; Karvonen J; Pelkonen O
Arch Dermatol Res; 1982; 273(1-2):103-9. PubMed ID: 7184465
[TBL] [Abstract][Full Text] [Related]
13. Age and the rate of induction of aryl hydrocarbon hydroxylase in isolated peripheral blood monocytes.
George G; Wynne H; Woodhouse K
Age Ageing; 1991 Nov; 20(6):421-3. PubMed ID: 1776590
[TBL] [Abstract][Full Text] [Related]
14. Carcinogen metabolism and DNA adducts in human lung tissues as affected by tobacco smoking or metabolic phenotype: a case-control study on lung cancer patients.
Bartsch H; Petruzzelli S; De Flora S; Hietanen E; Camus AM; Castegnaro M; Geneste O; Camoirano A; Saracci R; Giuntini C
Mutat Res; 1991; 250(1-2):103-14. PubMed ID: 1944327
[TBL] [Abstract][Full Text] [Related]
15. Environmental factors and aryl hydrocarbon hydroxylase activity (CYP1A1 phenotype) in human lymphocytes.
Kiyohara C; Hirohata T
J Epidemiol; 1997 Dec; 7(4):244-50. PubMed ID: 9465551
[TBL] [Abstract][Full Text] [Related]
16. Aryl hydrocarbon hydroxylase activity in subpopulations of peripheral blood mononuclear cells.
Jett JR; Stobo JD; Moses HL
Cancer Res; 1978 Jul; 38(7):1979-82. PubMed ID: 306872
[TBL] [Abstract][Full Text] [Related]
17. Induction of aryl hydrocarbon hydroxylase activity in cultured human lymphocytes.
Suolinna EM; Vänttinen E; Aitio A
Toxicology; 1982; 24(1):73-84. PubMed ID: 7135405
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary drug-metabolizing enzyme in alveolar macrophages in relation to cigarette smoking.
Abe S; Makimura S; Ogura S; Nakajima I; Kawakami Y
Jpn J Med; 1990; 29(2):164-7. PubMed ID: 2232364
[TBL] [Abstract][Full Text] [Related]
19. Long-lasting effects of tobacco smoking on pulmonary drug-metabolizing enzymes: a case-control study on lung cancer patients.
Petruzzelli S; Camus AM; Carrozzi L; Ghelarducci L; Rindi M; Menconi G; Angeletti CA; Ahotupa M; Hietanen E; Aitio A
Cancer Res; 1988 Aug; 48(16):4695-700. PubMed ID: 3135117
[TBL] [Abstract][Full Text] [Related]
20. [AHH activity and life environmental factors].
Nagayama J
Gan No Rinsho; 1987 Apr; 33(5 Suppl):549-54. PubMed ID: 3599463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
